TABLE 2.
Antimicrobial gene expression in response to feeding
| Antimicrobial | Tissue | No. of replicates (control, challenged)a | Median difference (n-fold) (negative difference [n-fold])b,d | 95% CIc | P valued |
|---|---|---|---|---|---|
| Defensin-1 | Fat body | 3, 3 | +1.192 | 1.183-1.201 | 0.0893 |
| Midgut | 3, 3 | +35.34 | 35.09-35.60 | 5.812E−12 | |
| Defensin 2 | Fat body | 4, 5 | +1.005 | 0.9770-1.034 | 0.9787 |
| Midgut | 4, 4 | +5.140 | 4.995-5.289 | 2.091E−06 | |
| Lysozyme | Fat body | 3, 3 | 0.0585 (−17.09) | 0.0087-0.3938 | 0.0138 |
| Midgut | 3, 3 | 0.6047 (−1.654) | 0.0899-4.070 | 0.0912 |
Numbers of replicated experiments in which one tick served as a replicate.
The difference (n-fold) is calculated as the ratio of normalized median values for challenged ticks to normalized median values for control ticks. Ratios of ≤1 are represented as −1/median difference (n-fold).
95% confidence intervals (95% CI) were calculated for the experimental median difference (n-fold) data by using the population variance derived as described by Price and Bonett (36) and Bonett and Price (1).
Results for fed ticks were said to be significantly different from those for unfed ticks if the experimental median difference (n-fold) exceeded the upper or lower limit of the 95% confidence interval calculated for each antimicrobial population data set by using methods described by Price and Bonett (36) and Bonett and Price (1). Defensin-1 population critical limits, 0.9905 and 1.010; defensin-2 population critical limits, 0.8348 and 0.9001; lysozyme population critical limits, 0.0813 and 12.30. P values were derived from the antimicrobial population distributions as described in the appendix.